infektiopod
by infektiopod
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 3 chart positions in 3 markets.
By chart position
- 🇩🇪DE · Science#1705K to 30K
- 🇦🇹AT · Science#643K to 10K
- 🇭🇺HU · Science#108500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
4.3K to 22K🎙 Weekly cadence·100 episodes·Last published 2mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
8.5K to 43K🇩🇪70%🇦🇹23%🇭🇺7% - Active Followers
Loyal subscribers who consistently listen
2.5K to 13K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 12 epsHost
Recent guests
Recent episodes
Infektiopod 109: Best of KIT 2026!
Jun 25, 2026
45m 20s
Infektiopod 108: Ausbruch-Update zu Hantavirus & Ebola Bundibugyo
Jun 7, 2026
1h 05m 37s
Infektiopod 107: ESCMID-News zu Blutstrominfektionen & AI
May 5, 2026
1h 14m 02s
Infektiopod 106: Endemische Systemmykosen
Apr 8, 2026
1h 05m 06s
Infektiopod 105: Immunologie der Sepsis
Feb 26, 2026
1h 00m 06s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/25/26 | InfektionskrankheitenTropenmedizin+3 | — | FEN-AUREUS-StudyFEN-AUREUS calculator+4 | Köln | KITInfektionskrankheiten+7 | — | 45m 20s | ||
| 6/7/26 | Hantavirus outbreakEbola outbreak+4 | — | JIKI-TrialRKI+2 | DRC | HantavirusEbola+5 | — | 1h 05m 37s | ||
| 5/5/26 | BlutstrominfektionenAI in der Infektiologie+3 | Till | ESCMIDSNAP-Trial | Europäischen Gesellschaft für klinische Mikrobiologie und Infektionskrankheiten | BlutstrominfektionenAI+6 | — | 1h 14m 02s | ||
| 4/8/26 | endemic systemic mycosesHistoplasmosis+4 | Prof. Dr. Ralf Bialek | Infektiopod 106: Endemische Systemmykosen | — | endemic mycosesHistoplasmosis+5 | — | 1h 05m 06s | ||
| 2/26/26 | ImmunologySepsis+3 | Martin Winkler | European Group on Immunology of Sepsis | Göttingen | sepsisimmunology+3 | — | 1h 00m 06s | ||
| 2/2/26 | Infectious DiseaseTuberculosis+3 | — | TuberkuloseStaphylococcus aureus+1 | — | infectious diseasetuberculosis+5 | — | 55m 29s | ||
| 1/7/26 | HIV therapyinfectious diseases+3 | Björn Jensen | Uniklinik DüsseldorfLancet ID | — | HIVtherapy+4 | — | 47m 05s | ||
| 12/2/25 | HIVimmunology+3 | Björn Jensen | Uniklinik Düsseldorf | — | HIV healingimmunology+3 | — | 43m 00s | ||
| 11/25/25 | HIVhealing+3 | Marc Franke | Naturestern TV | Düsseldorf | HIVhealing+5 | — | 45m 39s | ||
| 10/29/25 | EndocarditisMalaria+3 | — | Infective EndocarditisMalaria+1 | — | endocarditismalaria+3 | — | 1h 08m 51s | ||
| 10/8/25 | Candidiasisinvasive fungal infections+3 | Rosanne SpruteOliver Cornely | Uniklinik KölnEuropäisches Exzellenzzentrum für invasive Pilzinfektionen | — | Candidiasisfungal infections+3 | — | 1h 17m 57s | ||
| 8/22/25 | Sepsisantimicrobial therapy+3 | — | S3-Leitlinie Sepsis | — | sepsisantimicrobial therapy+3 | — | 42m 40s |
Showing 12 of 12
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for infektiopod
Peaked at #64 in AT, currently #64 in AT.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| AT | — | #64 | #64 | — |
| HU | — | #108 | #108 | — |
| Germany | — | #170 | #170 | — |
Chart Positions
3 placements across 3 markets.
Chart Positions
3 placements across 3 markets.